Dr Héloïse Bourbier

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Dr Héloïse Bourbier is 0.3% (very low). The 2024 annual accounts show equity of €104k and a net result of €46k. Equity is growing by ~36.9% per year across the filed fiscal years. Its solvency ranks better than 85% of 6584 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Signals

3 signals · with evidence

Strong solvency vs sector

Solvency is in the sector's strongest quartile: better than 85% of 6584 peers (2024). A comfortable equity buffer.

View the sector comparison

Consistently profitable

Positive net result in the two most recent financial years (2023 and 2024).

View the result trend

Growing equity

Equity grew over 2022-2024. Profits are largely retained rather than distributed.

View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Deadline passed, not yet counted as missing

The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 19 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.

Latest accounts filed on time

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-06-2025, 31 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.

How we compute the deadline

The year end is derived from 3 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	30-06-2025	31 d early	2025-00204291
31-12-2023	31-07-2024	16-06-2024	45 d early	2024-00135187
31-12-2022	31-07-2023	29-06-2023	32 d early	2023-00174893

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

More than 3 years active

Founded in 2021, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.3% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Young company +Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€46k+208.0%

Working capital€101k+64.4%

CSV export

Annual accounts & ratios

Source: NBB · 2024

Annual accounts filed on 30-06-2025 with the NBB · fiscal year 2024 · micro

Operating resultNet result

Trajectory (indicative)

Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.

growing Equity: growth of ~36.9%/year over 3 fiscal years, indicative, assuming unchanged policy.

Solid line = filed figures · dashed = extended trend · area = indicative range.

How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison

Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	88.9%	66.7%	better than 85% of 6584 sector peers
Net result	€46k	€46k	better than 50% of 6578 sector peers
Equity	€104k	€79k	better than 58% of 6584 sector peers
Gross operating margin	€61k	€78k	better than 41% of 6586 sector peers
Total assets	€117k	€154k	better than 40% of 6587 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

Sector position over time

Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).

Solvency P85

Improving position over 2022-2024 · n=3685-6584

Net result P50

Stable position over 2022-2024 · n=3683-6578

Equity P58

Stable position over 2022-2024 · n=3685-6584

Gross operating margin P41

Stable position over 2022-2024 · n=3681-6586

Describes the position versus peers, not a forecast.

EBITDA

€60k

+165.7% 22-24

Net profit

€46k

+208.0% 22-24

Cash flow

€48k

+174.4% 22-24

Total assets

€117k

+58.5% 22-24

Equity

€104k

+52.2% 22-24

Working capital

€101k

+64.4% 22-24

Income taxes

€13k

+136.3% 22-24

Debt

€13k

+138.3% 22-24

Show 8 other metrics

Debt ≤ 1y

€13k

+141.8% 22-24

Current ratio

8.78

-29.5% 22-24

Quick ratio

8.78

-29.5% 22-24

Solvency

88.9%

-4.0% 22-24

Debt / equity

0.12

+56.6% 22-24

ROE

43.9%

+102.4% 22-24

ROA

39.1%

+94.3% 22-24

Interest coverage

349.20

+38.5% 22-24

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2024
Deposit	micro
Revenue	-
EBITDA	€60k
Net profit	€46k
Cash flow	€48k
Staff costs	-
Income taxes	€13k
Dividends	-
Total assets	€117k
Equity	€104k
Debt	€13k
of which ≤ 1y	€13k
of which > 1y	-
Working capital	€101k
Employees (FTE)	-

Ratios (computed)

	2024
Current ratio	8.78
Quick ratio	8.78
Working capital ratio	86.3%
Solvency	88.9%
Debt / equity	0.12
Long-term debt ratio	-
Interest coverage	349.20
Gross margin	-
Net margin	-
ROA	39.1%
ROE	43.9%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2024

Assets

Fixed assets €3k · 2.7% Current assets €113k · 97.3%

Equity & liabilities

Equity €104k · 88.9% Debt €13k · 11.1%

Full annual accounts (22 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€117k
Fixed assets	21/28	€3k
Tangible fixed assets	22/27	€3k
Current assets	29/58	€113k
Amounts receivable within one year	40/41	€9k
Cash & bank	54/58	€105k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€117k
Equity	10/15	€104k
Contributions / capital	10/11	€4k
Reserves	13	€54k
Accumulated profits (losses)	14	€46k
Amounts payable	17/49	€13k
Amounts payable within one year	42/48	€13k
Trade debts payable within one year	44	€237
Income statement
Gross operating margin	9900	€61k
Operating result	9901	€58k
Financial income	75	€373
Financial charges	65	€173
Result before taxes	9903	€58k
Income taxes	67/77	€13k
Net result for the period	9904	€46k
Result to be appropriated	9905	€46k

This table shows the latest fiscal year. 2 prior years, with figures and ratios, belong to a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2024 · computed

100 / 100 Excellent

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register

exact location from the address register On OpenStreetMap

6 companies at this address See who is registered here

Establishment units

1 location

Dr Héloïse Bourbier

Wijnheuvelenstraat 237, 1030 SchaarbeekActiviteiten van medisch specialisten

since 20212.319.785.583

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels1

Ground area5,589 m²

Buildings1

Building footprint422 m²

Volume (LiDAR)5,984 m³

Tallest building18.0 m · ±5 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 1 (100%)